1. Home
  2. USNA vs AUTL Comparison

USNA vs AUTL Comparison

Compare USNA & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

N/A

Current Price

$14.65

Market Cap

397.1M

Sector

Health Care

ML Signal

N/A

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

N/A

Current Price

$1.86

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USNA
AUTL
Founded
1992
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
596.2M
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
USNA
AUTL
Price
$14.65
$1.86
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $8.73
AVG Volume (30 Days)
146.5K
★ 1.4M
Earning Date
10-21-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,060,902,000.00
$10,120,000.00
Revenue This Year
N/A
$98.68
Revenue Next Year
$4.43
$28.47
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 496.00
52 Week Low
$12.57
$1.18
52 Week High
$27.95
$2.58

Technical Indicators

Market Signals
Indicator
USNA
AUTL
Relative Strength Index (RSI) 45.29 43.44
Support Level $14.00 $1.84
Resistance Level $15.75 $1.92
Average True Range (ATR) 0.47 0.09
MACD 0.10 -0.01
Stochastic Oscillator 26.63 34.48

Price Performance

Historical Comparison
USNA
AUTL

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: